GSK3B and early-onset autosomal dominant Alzheimer disease: We next studied the same issue in a model with GSK-3β overexpression in the forebrain (Tet/GSK-3β mice) that was previously demonstrated to display an Alzheimer’s disease-like phenotype [27].